Pulsenmore Ltd

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026

Company Profile

IndustryMedical Devices

SectorHealthcare

ExchangeNASDAQ

Market Capitalization11.64 mln

Float3.86 mln

Piotroski F-Score

4 / 9

Borderline

Relative Strength

18 / 100

Significantly lagging

Debt / Equity

0.71

Moderate leverage

Pre-Tax Margin

-66%

Severely loss-making

ROE

-40.45

Deeply negative

Altman Z-Score

-0.52

Deeply distressed

Business Description

Pulsenmore, founded in 2014 and headquartered in Omer, Israel, makes it possible for patients to perform their own ultrasound scans at home using a small device that connects to a smartphone. The images and video are sent securely to the cloud, where doctors in Israel and Europe can review them or provide live guidance during the scan.

Key Fundamentals

EPS-1.33

ROE-40.45

RPS2.26

ROIC-30.28

ROA-25.86

Interest Cover-1.78

EBITDA, mln-2.43

EV / EBITDA-1.60

EV / EBIT-1.16

Revenue, mln12.90

EV / Revenue0.30

Quote Details

Last 1.67

Change 0.05 (3.09%)

Open 1.80

Volume 11,315

Turnover 18,896

Average Volume 28,412

Financial Ratios

Pre-Tax Profit Margin-66

Leverage Ratio2.07

Current Ratio1.84

Price / Book0.98

Price / Tangible Book0.98

Debt / Equity0.71

Price / Sales1.13

Financial Strength

Altman Z-Score-0.52

Piotroski F-Score 4 / 9

Short Ratio0.08

Short % of Float0.21

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-5.65%	16 / 100
1 Month	-24.77%	15 / 100
2 Months	-51.31%	8 / 100
6 Months	-53.22%	12 / 100